JP2025500926A5 - - Google Patents
Info
- Publication number
- JP2025500926A5 JP2025500926A5 JP2024536287A JP2024536287A JP2025500926A5 JP 2025500926 A5 JP2025500926 A5 JP 2025500926A5 JP 2024536287 A JP2024536287 A JP 2024536287A JP 2024536287 A JP2024536287 A JP 2024536287A JP 2025500926 A5 JP2025500926 A5 JP 2025500926A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- tissue
- sequences
- patient
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21215594.9 | 2021-12-17 | ||
| EP21215594 | 2021-12-17 | ||
| EP22187561.0 | 2022-07-28 | ||
| EP22187561 | 2022-07-28 | ||
| PCT/EP2022/086444 WO2023111306A1 (en) | 2021-12-17 | 2022-12-16 | Personalized cancer therapy targeting normally non-expressed sequences |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500926A JP2025500926A (ja) | 2025-01-15 |
| JP2025500926A5 true JP2025500926A5 (https=) | 2025-12-18 |
Family
ID=84943771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024536287A Pending JP2025500926A (ja) | 2021-12-17 | 2022-12-16 | 通常発現されない配列を標的とする個別化されたがん治療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250054576A1 (https=) |
| EP (1) | EP4449420A1 (https=) |
| JP (1) | JP2025500926A (https=) |
| AU (1) | AU2022409746B2 (https=) |
| CA (1) | CA3241220A1 (https=) |
| WO (1) | WO2023111306A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025158034A1 (en) | 2024-01-24 | 2025-07-31 | Evaxion Biotech A/S | Method for optimizing selection of an effective vaccine agent |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2017507C (en) | 1989-05-25 | 1996-11-12 | Gary Van Nest | Adjuvant formulation comprising a submicron oil droplet emulsion |
| US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
| CA3058807A1 (en) * | 2017-04-03 | 2018-10-11 | Biontech Us Inc. | Protein antigens and uses thereof |
| WO2020141207A1 (en) | 2019-01-03 | 2020-07-09 | Evaxion Biotech Aps | Vaccines targeting neoepitopes |
| US20220184191A1 (en) | 2019-03-11 | 2022-06-16 | Evaxion Biotech A/S | Nucleic acid vaccination using neo-epitope encoding constructs |
| EP3994156A1 (en) | 2019-07-05 | 2022-05-11 | The Francis Crick Institute Limited | Novel cancer antigens and methods |
| WO2021123232A1 (en) | 2019-12-18 | 2021-06-24 | Evaxion Biotech Aps | Nucleic acid vaccination using neo-epitope encoding constructs |
| IT202000006973A1 (it) * | 2020-04-02 | 2021-10-02 | Istituto Naz Tumori Irccs Fondazione G Pascale | Antigeni herv tumore-specifici e loro uso nella immunoterapia del cancro |
| US20230147574A1 (en) | 2020-04-07 | 2023-05-11 | Evaxion Biotech A/S | Neoepitope immunotherapy with APC targeting unit |
-
2022
- 2022-12-16 US US18/719,468 patent/US20250054576A1/en active Pending
- 2022-12-16 AU AU2022409746A patent/AU2022409746B2/en active Active
- 2022-12-16 WO PCT/EP2022/086444 patent/WO2023111306A1/en not_active Ceased
- 2022-12-16 CA CA3241220A patent/CA3241220A1/en active Pending
- 2022-12-16 JP JP2024536287A patent/JP2025500926A/ja active Pending
- 2022-12-16 EP EP22843138.3A patent/EP4449420A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7712970B2 (ja) | ホットスポットを利用した新生抗原の特定 | |
| CN111868080B (zh) | 利用泛等位基因模型进行的新抗原鉴别 | |
| US20170202939A1 (en) | Personalized cancer vaccines and methods therefor | |
| JP7763588B2 (ja) | Ｔ細胞療法用の新生抗原の特定法 | |
| CN107430132B (zh) | 预测可用于疫苗接种的t细胞表位 | |
| JP2023103405A (ja) | 共通ネオ抗原 | |
| JP2021525076A (ja) | 共有抗原 | |
| CA2965033C (en) | Methods and compositions for diagnosis and treatment of glioblastoma | |
| JP2017524337A5 (https=) | ||
| JP2019513021A (ja) | ネオエピトープ提示のための配列の配置および配列 | |
| JP2005537800A5 (https=) | ||
| JP2017525336A5 (https=) | ||
| US20260094669A1 (en) | Epitope prediction via a learned genotype network across class ii mhc alleles | |
| EP3827261A1 (en) | Method of preparing subject-specific immunogenic compositions based on a neo open-reading-frame peptide database | |
| EP4241274A1 (en) | Selecting neoantigens for personalized cancer vaccine | |
| CN121713244A (zh) | 选择用于开发个体化癌症疫苗的新抗原的方法 | |
| JP2025500926A5 (https=) | ||
| JP2022532271A5 (https=) | ||
| US20250044293A1 (en) | Personalized ranking and identification of onco-reactive t cell receptors and uses thereof | |
| James | HLA-based Immunotherapy for Cancer | |
| CN120500347A (zh) | 用于针对急性髓性白血病（aml）和其它血液肿瘤的免疫疗法的肽和肽的组合 | |
| Himuro et al. | Personalized Cancer Vaccines Targeting Neoantigens | |
| HK40129773A (en) | Neoantigen identification using hotspots | |
| WO2024073726A2 (en) | Personalized muc1-c induced pluripotent stem cell and dendritic cell based vaccines | |
| HK40061504A (en) | Predicting t cell epitopes useful for vaccination |